Anti-PD-1 immunotherapy for the treatment of metastatic urothelial carcinoma in a kidney transplant recipient: a case report

Abstract Background Immune checkpoint inhibitor (ICI) therapy has been widely investigated in urothelial carcinoma; however, the utility of ICI therapy in the treatment of organ transplant recipients with metastatic urothelial carcinoma (mUC) is unclear. We herein report the first case of a first-li...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Houfeng Huang, Ziyi Dai, Ziming Jiang, Xiaoyuan Li, Lin Ma, Zhigang Ji, Xinrong Fan
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2024-10-01
coleção:	BMC Nephrology
Assuntos:	Metastatic urothelial carcinoma (mUC) Immune checkpoint inhibitor (ICI) Tislelizumab Kidney transplant Partial response Case report
Acesso em linha:	https://doi.org/10.1186/s12882-024-03825-2
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!